Pharma major Lupin LTD on Thursday said that it has appointed Johnny Mikell as its President and Global Head of Quality. Johnny will be based out of Lupin’s US offices and will lead the company’s quality function globally. He will also help steer the company towards enhanced standards of quality and compliance. “Johnny brings to Lupin over 35 years of rich pharmaceutical industry experience and expertise,” the pharma major said in a statement. In his most recent engagement, Johnny was the Global Head of Quality and Compliance at Apotex and prior to that, he also served as the Global Head of Quality and Compliance at Amneal.